PRFX Q2 2024 Earnings EPS Misses Estimates as Company Continues Development Stage ProKidney Corp PROK Q1 2026 Earnings Narrowed Loss and Steady Progress in Kidney Disease Therapy Investors Title Company Q4 2025 Earnings EPS of 397 Reported Stock Edges Lower UMC Q1 2026 Earnings Massive EPS Beat Signals Strong Operational Leverage KPRX Q1 2026 Earnings NarrowerthanExpected Loss Fails to Lift Shares HLX Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds